Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 42


2-amino-1-methyl-6-phenylimidazo(4,5-b) pyridine (PhIP) induces gene expression changes in JAK/STAT and MAPK pathways related to inflammation, diabetes and cancer.

Rogers LJ, Basnakian AG, Orloff MS, Ning B, Yao-Borengasser A, Raj V, Kadlubar S.

Nutr Metab (Lond). 2016 Aug 20;13:54. doi: 10.1186/s12986-016-0111-0.


Effect of MRP2 and MRP3 Polymorphisms on Anastrozole Glucuronidation and MRP2 and MRP3 Gene Expression in Normal Liver Samples.

Edavana VK, Penney RB, Yao-Borengasser A, Starlard-Davenport A, Dhakal IB, Kadlubar S.

Int J Cancer Res Mol Mech. 2015 Oct;1(3). doi: 10.16966/2381-3318.112.


Modulation of ALDH5A1 and SLC22A7 by microRNA hsa-miR-29a-3p in human liver cells.

Yu D, Tolleson WH, Knox B, Jin Y, Guo L, Guo Y, Kadlubar SA, Ning B.

Biochem Pharmacol. 2015 Dec 15;98(4):671-80. doi: 10.1016/j.bcp.2015.09.020.


Human UDP-Glucuronosyltransferases: Effects of altered expression in breast and pancreatic cancer cell lines.

Dates CR, Fahmi T, Pyrek SJ, Yao-Borengasser A, Borowa-Mazgaj B, Bratton SM, Kadlubar SA, Mackenzie PI, Haun RS, Radominska-Pandya A.

Cancer Biol Ther. 2015;16(5):714-23. doi: 10.1080/15384047.2015.1026480.


Adipocyte hypoxia promotes epithelial-mesenchymal transition-related gene expression and estrogen receptor-negative phenotype in breast cancer cells.

Yao-Borengasser A, Monzavi-Karbassi B, Hedges RA, Rogers LJ, Kadlubar SA, Kieber-Emmons T.

Oncol Rep. 2015 Jun;33(6):2689-94. doi: 10.3892/or.2015.3880.


Suppression of CYP2C9 by microRNA hsa-miR-128-3p in human liver cells and association with hepatocellular carcinoma.

Yu D, Green B, Marrone A, Guo Y, Kadlubar S, Lin D, Fuscoe J, Pogribny I, Ning B.

Sci Rep. 2015 Feb 23;5:8534. doi: 10.1038/srep08534.


Genotypic and allelic variability in CYP19A1 among populations of African and European ancestry.

Starlard-Davenport A, Orloff MS, Dhakal I, Penney RB, Kadlubar SA.

PLoS One. 2015 Feb 3;10(2):e0117347. doi: 10.1371/journal.pone.0117347.


Pharmacogenetics of SULT1A1.

Daniels J, Kadlubar S.

Pharmacogenomics. 2014 Nov;15(14):1823-1838.


Cross-sectional study to assess the association of population density with predicted breast cancer risk.

Lee JY, Klimberg S, Bondurant KL, Phillips MM, Kadlubar SA.

Breast J. 2014 Nov-Dec;20(6):615-21. doi: 10.1111/tbj.12330.


CYP19A1 single nucleotide polymorphism associations with CYP19A1, NFκB1, and IL6 gene expression in human normal colon and normal liver samples.

Penney RB, Lundgreen A, Yao-Borengasser A, Edavana VK, Williams S, Dhakal I, Wolff RK, Kadlubar S, Slattery ML.

Pharmgenomics Pers Med. 2014 Jul 14;7:163-71. doi: 10.2147/PGPM.S62238.


A potential role for human UDP-glucuronosyltransferase 1A4 promoter single nucleotide polymorphisms in the pharmacogenomics of tamoxifen and its derivatives.

Greer AK, Dates CR, Starlard-Davenport A, Edavana VK, Bratton SM, Dhakal IB, Finel M, Kadlubar SA, Radominska-Pandya A.

Drug Metab Dispos. 2014 Sep;42(9):1392-400. doi: 10.1124/dmd.114.058016.


High-circulating Tie2 Is Associated With Pathologic Complete Response to Chemotherapy and Antiangiogenic Therapy in Breast Cancer.

Makhoul I, Griffin RJ, Siegel E, Lee J, Dhakal I, Raj V, Jamshidi-Parsian A, Klimberg S, Hutchins LF, Kadlubar S.

Am J Clin Oncol. 2016 Jun;39(3):248-54. doi: 10.1097/COC.0000000000000046.


Sulfotransferase 1A1 (SULT1A1) gene expression is regulated by members of the NFI transcription factors in human breast cancer cells.

Yao-Borengasser A, Rogers LJ, Edavana VK, Penney RB, Yu X, Dhakal IB, Williams S, Kadlubar SA.

BMC Clin Pathol. 2014 Jan 6;14(1):1. doi: 10.1186/1472-6890-14-1.


Fulvestrant up regulates UGT1A4 and MRPs through ERα and c-Myb pathways: a possible primary drug disposition mechanism.

Edavana VK, Penney RB, Yao-Borengasser A, Williams S, Rogers L, Dhakal IB, Kadlubar S.

Springerplus. 2013 Nov 20;2:620. doi: 10.1186/2193-1801-2-620.


Polymorphisms of ERBB2 and breast cancer risk: a meta-analysis of 26 studies involving 35,088 subjects.

Kadlubar SA.

J Surg Oncol. 2013 Nov;108(6):335-6. doi: 10.1002/jso.23404. No abstract available.


Lack of correlation between in silico projection of function and quantitative real-time PCR-determined gene expression levels in colon tissue.

Penney RB, Lundgreen A, Yao-Borengasser A, Koroth-Edavana V, Williams S, Wolff R, Slattery ML, Kadlubar S.

Pharmgenomics Pers Med. 2013 Sep 9;6:99-103. doi: 10.2147/PGPM.S49199.


Sulfotransferase genetic variation: from cancer risk to treatment response.

Daniels J, Kadlubar S.

Drug Metab Rev. 2013 Nov;45(4):415-22. doi: 10.3109/03602532.2013.835621. Review.


Copy number variation in sulfotransferase isoform 1A1 (SULT1A1) is significantly associated with enzymatic activity in Japanese subjects.

Yu X, Kubota T, Dhakal I, Hasegawa S, Williams S, Ozawa S, Kadlubar S.

Pharmgenomics Pers Med. 2013;6:19-24. doi: 10.2147/PGPM.S36579.


GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer.

Zhang X, Huang M, Wu X, Kadlubar S, Lin J, Yu X, Fan C, Ning B, Kadlubar FF.

Pharmgenomics Pers Med. 2013;6:9-17. doi: 10.2147/PGPM.S35949.


Potential role of UGT1A4 promoter SNPs in anastrozole pharmacogenomics.

Edavana VK, Dhakal IB, Williams S, Penney R, Boysen G, Yao-Borengasser A, Kadlubar S.

Drug Metab Dispos. 2013 Apr;41(4):870-7. doi: 10.1124/dmd.112.048157.

Items per page

Supplemental Content

Loading ...
Support Center